Elevated baseline D-dimer plasma levels are associated with a prompt response to omalizumab in patients with severe CSU

MeSH terms

• Adolescent
• Adult
• Aged
• Anti-Allergic Agents / therapeutic use*
• Biomarkers, Pharmacological / metabolism*
• Blood Proteins / metabolism*
• Chronic Disease
• Female
• Fibrin Fibrinogen Degradation Products / metabolism*
• Humans
• Male
• Middle Aged
• Omalizumab / therapeutic use*
• Urticaria / diagnosis
• Urticaria / drug therapy*
• Young Adult